Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Saima Amin, Mays AlJboor, Mario D Toro, Robert Rejdak, Katarzyna Nowomiejska, Rashed Nazzal, Mona Mohammad, Maysa Al-Hussaini, Jakub Khzouz, Sara Banat, Reem AlJabari, Imad Jaradat, Mustafa Mehyar, Iyad Sultan, Ibrahim AlNawaiseh & Yacoub A Yousef. (2021) Management and Outcomes of Unilateral Group D Tumors in Retinoblastoma. Clinical Ophthalmology 15, pages 65-72.
Read now
Read now
Iyad Sultan, Yasmin Hajja, Ibrahim Nawaiseh, Mustafa Mehyar, Rasha Deebajah, Imad Jaradat & Yacoub A. Yousef. (2016) Chemoreduction of Progressive Intraocular Retinoblastoma by Systemic Topotecan. Ophthalmic Genetics 37:2, pages 209-213.
Read now
Read now
Rachel C Brennan, Eleanor M Pritchard, R Kiplin Guy, Michael A Dyer & Matthew W Wilson. (2015) Current and emerging therapy for improving outcomes in patients with intraocular retinoblastoma. Expert Opinion on Orphan Drugs 3:10, pages 1155-1166.
Read now
Read now
Articles from other publishers (29)
Swathi Kaliki, Suneetha Gavara, Gaurav Patil & Vijay Anand Reddy Palkonda. (2024) SECONDARY SALVAGE INTRAVENOUS CHEMOTHERAPY FOR REFRACTORY/RECURRENT RETINOBLASTOMA. Retina 44:1, pages 144-150.
Crossref
Crossref
Elham Delrish, Mahmoud Jabbarvand, Fariba Ghassemi, Fahimeh Asadi Amoli, Fatemeh Atyabi, Alireza Lashay, Masoud Soleimani, Leila Aghajanpour & Rassoul Dinarvand. (2021) Efficacy of topotecan nanoparticles for intravitreal chemotherapy of retinoblastoma. Experimental Eye Research 204, pages 108423.
Crossref
Crossref
Raksha Rao, Santosh G Honavar, Vishal Sharma & Vijay Anand P Reddy. (2018) Intravitreal topotecan in the management of refractory and recurrent vitreous seeds in retinoblastoma. British Journal of Ophthalmology 102:4, pages 490-495.
Crossref
Crossref
PurnimaR Sthapit, Raksha Rao & SantoshG Honavar. (2018) Periocular topotecan for vitreous seeds in retinoblastoma. Indian Journal of Ophthalmology 66:12, pages 1833.
Crossref
Crossref
Guillem Pascual-Pasto, Nagore G. Olaciregui, Javier A.W. Opezzo, Helena Castillo-Ecija, Maria Cuadrado-Vilanova, Sonia Paco, Ezequiel M. Rivero, Monica Vila-Ubach, Camilo A. Restrepo-Perdomo, Montserrat Torrebadell, Mariona Suñol, Paula Schaiquevich, Jaume Mora, Guillermo F. Bramuglia, Guillermo L. Chantada & Angel M. Carcaboso. (2017) Increased delivery of chemotherapy to the vitreous by inhibition of the blood-retinal barrier. Journal of Controlled Release 264, pages 34-44.
Crossref
Crossref
Paula Taich, Maria Del Sole, Fabian Buontempo, Gustavo Williams, Ursula Winter, Mariana Sgroi, Guillermo Chantada & Paula Schaiquevich. (2017) Ocular topotecan pharmacokinetics following topical administration to rabbits for diffused anterior retinoblastoma. Journal of Pharmacy and Pharmacology 69:5, pages 574-581.
Crossref
Crossref
Rachel C. BrennanIbrahim QaddoumiShenghua MaoJianrong WuCatherine A. BillupsClinton F. StewartMary Ellen HoehnCarlos Rodriguez-GalindoMatthew W. Wilson. (2017) Ocular Salvage and Vision Preservation Using a Topotecan-Based Regimen for Advanced Intraocular Retinoblastoma. Journal of Clinical Oncology 35:1, pages 72-77.
Crossref
Crossref
Paula Schaiquevich, Armida W. Fabius, Jasmine H. Francis, Guillermo L. Chantada & David H. Abramson. (2017) OCULAR PHARMACOLOGY OF CHEMOTHERAPY FOR RETINOBLASTOMA. Retina 37:1, pages 1-10.
Crossref
Crossref
Paula Taich, Marcela A. Moretton, María Jose Del Sole, Ursula Winter, Ezequiel Bernabeu, Juan O. Croxatto, Javier Oppezzo, Gustavo Williams, Guillermo L. Chantada, Diego A. Chiappetta & Paula Schaiquevich. (2016) Sustained-release hydrogels of topotecan for retinoblastoma. Colloids and Surfaces B: Biointerfaces 146, pages 624-631.
Crossref
Crossref
Angela Ferrario, Marian Luna, Natalie Rucker, Sam Wong, Ariel Lederman, Jonathan Kim & Charles Gomer. (2016) Targeting Survivin Enhances Chemosensitivity in Retinoblastoma Cells and Orthotopic Tumors. PLOS ONE 11:4, pages e0153011.
Crossref
Crossref
Pia R. MendozaHans E. Grossniklaus. (2016) Therapeutic Options for Retinoblastoma. Cancer Control 23:2, pages 99-109.
Crossref
Crossref
Jasmine H Francis, Brian P Marr, Paula Schaiquevich, Michael G Kellick & David H Abramson. (2015) Properties and clinical utility of topotecan fluorescence: uses for retinoblastoma. British Journal of Ophthalmology 99:10, pages 1320-1322.
Crossref
Crossref
Paulita Pamela P. Astudillo, Priya Durairaj, Helen S.L. Chan, Elise Héon & Brenda L. Gallie. (2015) Hypersensitivity to sub-Tenon's topotecan in fibrin adhesive in patients with retinoblastoma. Journal of American Association for Pediatric Ophthalmology and Strabismus 19:1, pages 86-87.
Crossref
Crossref
FairoozP Manjandavida & CarolL Shields. (2015) The role of intravitreal chemotherapy for retinoblastoma. Indian Journal of Ophthalmology 63:2, pages 141.
Crossref
Crossref
Paula Schaiquevich & Guillermo L. Chantada. 2015. Recent Advances in Retinoblastoma Treatment. Recent Advances in Retinoblastoma Treatment
61
72
.
Jeannette R. WongLindsay M. MortonMargaret A. TuckerDavid H. AbramsonJohanna M. SeddonJoshua N. SampsonRuth A. Kleinerman. (2014) Risk of Subsequent Malignant Neoplasms in Long-Term Hereditary Retinoblastoma Survivors After Chemotherapy and Radiotherapy. Journal of Clinical Oncology 32:29, pages 3284-3290.
Crossref
Crossref
Paula Schaiquevich, Angel M. Carcaboso, Emiliano Buitrago, Paula Taich, Javier Opezzo, Guillermo Bramuglia & Guillermo L. Chantada. (2014) OCULAR PHARMACOLOGY OF TOPOTECAN AND ITS ACTIVITY IN RETINOBLASTOMA. Retina 34:9, pages 1719-1727.
Crossref
Crossref
Paula Schaiquevich, Alejandro Ceciliano, Natalia Millan, Paula Taich, Francisco Villasante, Adriana C. Fandino, Julieta Dominguez & Guillermo L. Chantada. (2012) Intra‐arterial chemotherapy is more effective than sequential periocular and intravenous chemotherapy as salvage treatment for relapsed retinoblastoma. Pediatric Blood & Cancer 60:5, pages 766-770.
Crossref
Crossref
Emiliano Buitrago, María José Del Sole, Ana Torbidoni, Adriana Fandino, Marcelo Asprea, J.O. Croxatto, Guillermo L. Chantada, Guillermo F. Bramuglia & Paula Schaiquevich. (2013) Ocular and systemic toxicity of intravitreal topotecan in rabbits for potential treatment of retinoblastoma. Experimental Eye Research 108, pages 103-109.
Crossref
Crossref
Meng ZHANG, Bao-en SHAN, Nai-fen YUAN & Wei LIU. (2013) Effect of topotecan on retinocytoma cell apoptosis and expression of Livin and PTEN. Chinese Medical Journal 126:2, pages 340-344.
Crossref
Crossref
Denisa Darsova, Pavel Pochop, Jiri Uhlik, Eva Klapkova, Hundie Tesfaye, Daniela Kodetova, Jan Lestak, Josef Malis & Ludek Vajner. (2012) Topotecan vitreous and plasma levels and retinal toxicity after transcorneal intravitreal delivery in healthy albino rabbits: Alternative retinoblastoma treatment. Biomedical Papers 156:4, pages 318-323.
Crossref
Crossref
Ibrahim Qaddoumi, Catherine A. Billups, Michael Tagen, Clinton F. Stewart, Jianrong Wu, Kathleen Helton, M. Beth McCarville, Thomas E. Merchant, Rachel Brennan, Tammy M. Free, Vicki Given, Barrett G. Haik, Carlos Rodriguez‐Galindo & Matthew W. Wilson. (2012) Topotecan and vincristine combination is effective against advanced bilateral intraocular retinoblastoma and has manageable toxicity. Cancer 118:22, pages 5663-5670.
Crossref
Crossref
Paula Schaiquevich, Emiliano Buitrago, Alejandro Ceciliano, Adriana C. Fandino, Marcelo Asprea, Sergio Sierre, David H. Abramson, Guillermo F. Bramuglia & Guillermo L. Chantada. (2012) PHARMACOKINETIC ANALYSIS OF TOPOTECAN AFTER SUPERSELECTIVE OPHTHALMIC ARTERY INFUSION AND PERIOCULAR ADMINISTRATION IN A PORCINE MODEL. Retina 32:2, pages 387-395.
Crossref
Crossref
Emiliano Buitrago, Christian Höcht, Guillermo Chantada, Adriana Fandiño, Elliot Navo, David H. Abramson, Paula Schaiquevich & Guillermo F. Bramuglia. (2010) Pharmacokinetic analysis of topotecan after intra-vitreal injection. Implications for retinoblastoma treatment. Experimental Eye Research 91:1, pages 9-14.
Crossref
Crossref
C. Rodriguez-Galindo. 2010. Retinoblastoma. Retinoblastoma
67
90
.
K.F. TAM, Y.M. CHAN, T.Y. NG, L.C. WONG & H.Y.S. NGAN. (2006) Ethnicity is a factor to be considered before dose planning in ovarian cancer patients to be treated with topotecan. International Journal of Gynecological Cancer 16:1, pages 135-139.
Crossref
Crossref
Nikia A. Laurie, Jonathan K. Gray, Jiakun Zhang, Mark Leggas, Mary Relling, Merrill Egorin, Clinton Stewart & Michael A. Dyer. (2005) Topotecan Combination Chemotherapy in Two New Rodent Models of Retinoblastoma. Clinical Cancer Research 11:20, pages 7569-7578.
Crossref
Crossref
Constantino Sábado Álvarez, Ana Sastre Urgellés & José Manuel Abelairas Gómez. (2005) Uptate on retinoblastoma. Clinical and Translational Oncology 7:4, pages 174-178.
Crossref
Crossref
Guillermo L. Chantada, Adriana C. Fandiño, Elsa C. Raslawski, Julio Manzitti, Maria T.G. de Dávila, Sandra J. Casak, Marcelo J. Scopinaro & Enrique Schvartzman. (2004) Experience with chemoreduction and focal therapy for intraocular retinoblastoma in a developing country. Pediatric Blood & Cancer 44:5, pages 455-460.
Crossref
Crossref